10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2019
The DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Abstract
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“practice guidelines increasingly recognize the prevention of ischemic events as a key management priority.5,6”
In the citing paper
“However, subsequent trials that specifically examined the role of a blood pressure lowering strategy to <130 mm Hg in patients with T2DM and hypertension found no substantive benefit of intensive blood pressure control in reducing the risk of coronary events, although there was evidence for decreased risk of stroke.5,66–69”
In the citing paper
“As such, while all patients with T2DM and CAD certainly benefit from a blood pressure of <140/90 mm Hg,5,63–66,76”
In the citing paper
“ACE inhibitors/ARBs reduce the progression of kidney disease in patients with albuminuria (urine albumin-to-creatinine ratio ≥30 mg/g)5 and reduce the risk of both incident and recurrent atherosclerotic ischemic events.79,80”
In the citing paper
“Furthermore, fibrates or fish oil would be indicated when triglycerides are very high (>500 mg/dL) to reduce the risk of pancreatitis.5”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550
Research works printed but not linked: 2
- American College of Obstetricians and Gynecologists’, 2013, Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy, Obstet Gynecol, 122, 1122
- Fitchett, 2017, Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME trial, Eur Heart J, 39, 363, 10.1093/eurheartj/ehx511 · DOI · Paper page
Cited by
Items 101–200 of 470
Thambiah, S. C., & Lai, L. C. (2021) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2021.e00248 · Cited by 51
Zhang, M., Wu, J., Wang, Y., Wu, J., Hu, W., Jia, H., & Sun, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16830 · Cited by 39
Handelsman, Y. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01054-w · Cited by 34
Kubota, Y., & Shimizu, W. (2022) · JACC Asia · doi:10.1016/j.jacasi.2022.03.009 · Cited by 37
Wu, X., Gao, Y., Wang, M., Peng, H., Zhang, D., Qin, B., Pan, L., & Zhu, G. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-00992-4 · Cited by 31
Green, J. B., Everett, B. M., Ghosh, A., Younes, N., Krause-Steinrauf, H. J., Barzilay, J. I., Desouza, C. V., Inzucchi, S. E., Pokharel, Y., Schade, D. S., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.066604 · Cited by 30
Melo, L. G. N., Morales, P. H., Drummond, K. R. G., Santos, D. C., Pizarro, M., Barros, B. S. V., Mattos, T. C. L., Pinheiro, A. A., Mallmann, F., Leal, F. S. L., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00689 · Cited by 31
Semb, A. G., Rollefstad, S., Ikdahl, E., Wibetoe, G., Sexton, J., Crowson, C. S., van Riel, P. L. C. M., Kitas, G. D., Graham, I. M., Rantapää‐Dahlqvist, S., et al. (2021) · RMD Open · doi:10.1136/rmdopen-2021-001724 · Cited by 27
Villaschi, A., Ferrante, G., Cannata, F., Pini, D., Pagnesi, M., Corrada, E., Reimers, B., Mehran, R., Federici, M., Savarese, G., et al. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02362-6 · Cited by 31
Bandello, F. M., Toni, D., Porta, M., & Varano, M. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01453-z · Cited by 29
Bennich, B. B., Munch, L., Overgaard, D., Konradsen, H., Knop, F. K., Røder, M. E., Vilsbøll, T., & Egerod, I. (2019) · Journal of Advanced Nursing · doi:10.1111/jan.14256 · Cited by 57
Management of type 2 diabetes: consensus of diabetes organizations
Quattrocchi, E. J., Goldberg, T., & Marzella, N. (2020) · Drugs in Context · doi:10.7573/dic.212607 · Cited by 36
Consoli, A., Czupryniak, L., Duarte, R., Jermendy, G., Kautzky‐Willer, A., Mathieu, C., Melo, M., Mosenzon, O., Nobels, F. R. E., Παπάνας, Ν., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14102 · Cited by 26
Gut microbiome: A possible common therapeutic target for treatment of atherosclerosis and cancer
Wu, W., Ivanova, E. A., & Orekhov, A. N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.06.017 · Cited by 29
Lipid effects of sodium-glucose cotransporter 2 inhibitors
Lazarte, J., Kanagalingam, T., & Hegele, R. A. (2021) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000751 · Cited by 25
Gebrie, D., Manyazewal, T., Ejigu, D. A., & Makonnen, E. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s312997 · Cited by 28
Yang, Y., Kim, H., Kim, S., & Moon, M. K. (2023) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2023.12.1.12 · Cited by 30
Aschner, P. J., Galstyan, G. R., Yavuz, D. G., Litwak, L., González-Gálvez, G., Eliaschewitz, F. G., Hafidh, K., Djaballah, K., Tu, S., Unnikrishnan, A., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-00997-0 · Cited by 27
Ballasy, N., Jadli, A. S., Edalat, P., Kang, S., Hassanabad, A. F., Gomes, K. P., Fedak, P. W. M., & Patel, V. B. (2021) · The FASEB Journal · doi:10.1096/fj.202100684rr · Cited by 24
Kunneman, M., Branda, M. E., Ridgeway, J. L., Tiedje, K., May, C. R., Linzer, M., Inselman, J., Buffington, A. L. H., Coffey, J. D., Boehm, D. H., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02861-4 · Cited by 28
Yun, S. J., Jeong, I., Cha, J., Lee, J., Cho, H., Choi, S. H., Chun, S., Jeon, H. J., Kang, H., Kim, S. S., et al. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0088 · Cited by 27
Patoulias, D., Stavropoulos, K., Imprialos, K. P., Katsimardou, A., Kalogirou, M., Koutsampasopoulos, K., Zografou, I., Papadopoulos, C. E., Karagiannis, A. I., & Doumas, M. N. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107927 · Cited by 24
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits
Verma, S. (2019) · The American Journal of Medicine · doi:10.1016/j.amjmed.2019.08.007 · Cited by 25
“2,3 Both atherosclerotic cardiovascular disease and heart failure are major causes of morbidity and mortality in patients with type 2 diabetes mellitus, 4 and the reduction of cardiovascular risk remains an important goal in managing this patient group.”
Moulder, M. P. D., Hendricks, A. K., & Ou, N. N. (2019) · Clinical Cardiology · doi:10.1002/clc.23304 · Cited by 25
Giorgino, F., Vora, J. P., Fenici, P., & Solini, A. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14055 · Cited by 24
Identification and Predictors for Cardiovascular Disease Risk Equivalents Among Adults With Diabetes
Zhao, Y., Malik, S., Budoff, M. J., Correa, A., Ashley, K. E., Selvin, E., Watson, K. E., & Wong, N. D. (2021) · Diabetes Care · doi:10.2337/dc21-0431 · Cited by 22
Alsayed, N., Almahmeed, W. A., Alnouri, F., Al-Waili, K., Sabbour, H. M., Sulaiman, K., Zubaid, M., Ray, K. K., & Al‐Rasadi, K. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.11.022 · Cited by 25
Optimal blood pressure thresholds for minimal coronary artery disease risk in type 1 diabetes
Guo, J., Brooks, M. M., Muldoon, M. F., Naimi, A. I., Orchard, T. J., & Costacou, T. (2019) · Diabetes Care · doi:10.2337/dc19-0480 · Cited by 22
Armario, P., Brotons, C., Elosúa, R., de Leciñana, M. A., Castro, A., Clarà, A. B. I., Cortés, O., Rodríguez, Á. D., Herranz, M., Justo, S., et al. (2021) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2021.02.001 · Cited by 22
Li, M., Lu, J., Fu, J., Wan, Q., Wang, T., Huo, Y., Xu, Y., Xu, M., Zhao, Z., Chen, Y., et al. (2020) · PubMed · Cited by 26
Hong, J.-Y., Park, K., Kim, J.-D., Hwang, W.-M., & Lim, D.-M. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes20040 · Cited by 23
Lipoprotein (a) and diabetes mellitus: causes and consequences
Ward, N. C., Vickneswaran, S., & Watts, G. F. (2020) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000597 · Cited by 25
Managing thrombotic risk in patients with diabetes
Camm, A. J., Sabbour, H. M., Schnell, O., Summaria, F., & Verma, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01581-x · Cited by 28
Yang, Y., Kim, H., Kim, S., Moon, M. K., & Korean Society of Lipid and Atherosclerosis (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2022.0448 · Cited by 26
Alfian, S. D., Denig, P., Coelho, A., & Hak, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225390 · Cited by 27
Dorcely, B., Nitis, J., Schwartzbard, A. Z., Newman, J. D., Goldberg, I. J., & Sum, M. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200316112709 · Cited by 24
Kaul, S. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14648 · Cited by 22
Zhong, P., Zeng, H., Huang, M., He, G., & Chen, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.695182 · Cited by 27
Gaiţă, L., Timar, R. Z., Lupascu, N., Roman, D., Albai, A., Potre, O., & Timar, B. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s222570 · Cited by 24
Chellamma, J., Jabbar, P. K., Soumya, S., Jayakumar, R. V., Das, D., Girivishnu, G., Gopi, A., Gomez, R., Sreenath, R., & Nair, A. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0046 · Cited by 26
Zini, A., Mann, J., Mazor, S., & Vered, Y. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-52 · Cited by 20
Sahay, R. K., Mittal, V., Gopal, G. R., Kota, S. K., Goyal, G., Abhyankar, M., & Revenkar, S. (2020) · Cureus · doi:10.7759/cureus.10700 · Cited by 31
Cavero‐Redondo, I., Deeks, J. J., Álvarez‐Bueno, C., Jolly, K. B., Saz‐Lara, A., Price, M. J., Pascual‐Morena, C., & Martínez‐Vizcaíno, V. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003543 · Cited by 21
Malmborg, M. W., Schmiegelow, M., Gerds, T. A., Schou, M., Kistorp, C., Torp-Pedersen, C. T., & Gislason, G. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020395 · Cited by 20
Santamarina, M. L., & Carlson, C. J. (2019) · BMC Cardiovascular Disorders · doi:10.1186/s12872-019-1036-0 · Cited by 21
Wang, J., Wu, Y., Shin, S., Tien, K., Chin, M.-C., & Hwu, C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.06.017 · Cited by 20
Nicolucci, A., Candido, R., Cucinotta, D., Graziano, G., Rocca, A., Rossi, M. C., Tuccinardi, F., & Manicardi, V. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01043-z · Cited by 24
Primary Care Clinic Nurse Activities with a Telehealth Monitoring System
Howland, C., Despins, L. A., Sindt, J., Wakefield, B. J., & Mehr, D. R. (2020) · Western Journal of Nursing Research · doi:10.1177/0193945920923082 · Cited by 24
Kalra, S., Das, A. K., Baruah, M. P., Unnikrishnan, A., Dasgupta, A., Shah, P., Sahay, R. K., Shukla, R., Das, S., TIWASKAR, M. H., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0651-1 · Cited by 18
Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs
Schernthaner, G., Karasik, A., Abraitienė, A., As, A., Gaál, Z., Gumprecht, J., Janež, A., Kaser, S., Lalic, K. S., Mankovsky, B., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0920-3 · Cited by 20
Liao, K., Chang, C., Wang, S., Chang, Y., Chen, Y., & Wang, G. (2019) · Physiological Reports · doi:10.14814/phy2.14252 · Cited by 18
New Insights on Chronotherapy in Hypertension: Is Timing Everything?
Thoonkuzhy, C., & Rahman, M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1032-x · Cited by 21
Arshad, A., Sarween, N., & Sharif, A. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.06.029 · Cited by 20
The Diabetes-Heart Disease Connection: Recent Discoveries and Implications
Suman, S., Anupam, B., Kohaf, N. A., Singh, C., Johns, R., Pravalika, J., & Hastings, N. E. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101923 · Cited by 17
Godoy, L. C., Ko, D. T., Rao, V. A., & Farkouh, M. E. (2019) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2019.07.004 · Cited by 21
Zhang, W., Liu, C., Ji, L., Wang, J., & For the ATTEND investigators (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13793 · Cited by 19
Kim, H., Kim, H. M., Kwon, C. H., Shin, J., Jung, M., Lee, C. J., Kim, D., Kim, W.-H., Kang, S., Lee, J., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01156-8 · Cited by 19
Bouter, K. E. C., van Bommel, E. J. M., Jansen, H., van Harskamp, D., Schierbeek, H., Ackermans, M. T., Serlie, M. J. M., Schimmel, A. W. M., Nieuwdorp, M., Dallinga‐Thie, G. M., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13990 · Cited by 19
Jiang, Y., Yang, Z.-G., Wang, J., Shi, R., Han, P., Qian, W., Yan, W., & Li, Y. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01700-8 · Cited by 18
Prata, C. D., Renouf, B., Tzanis, D., Bouhadiba, T., Watson, S., Zein, S. E., Helfré, S., Nicolas, N., Perlbarg-Samson, J., Brenet, O., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13459-7 · Cited by 17
Laferrière, C., Moazzami, C., Belley‐Côté, E. P., Bainey, K. R., Marquis‐Gravel, G., Fama, A., Lordkipanidzé, M., & Potter, B. J. (2023) · CJC Open · doi:10.1016/j.cjco.2023.08.011 · Cited by 20
“36 The American Heart Association, in 2011, before the publication of much of the current body of evidence, established targeted recommendations for ASA use in women, patients with diabetes, and those aged over 65 years if blood pressure is well controlled and the ischemic bene fi ts are deemed to…”
BackgroundLin, M., Lee, C.-H., Lee, C.-H., Zou, Y.-F., Lu, C., Hsieh, C., & Lee, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050609 · Cited by 16
Personalized Management of Type 2 Diabetes
Peter, P. R., & Lupsa, B. C. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1244-0 · Cited by 17
O'Harte, F. P. M., Parthsarathy, V., & Flatt, P. R. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110695 · Cited by 17
Giménez‐Pérez, G., Franch‐Nadal, J., Ortega, E., Mata‐Cases, M., Goday, A., Real, J., Rodríguez, Á., Vlacho, B., & Mauricio, D. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071536 · Cited by 19
Meditative Movements for Patients with Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Xia, T., Yang, Y., Li, W., Tang, Z., Huang, Q., Li, Z., & Guo, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5745013 · Cited by 14
Jeon, J. Y., Ha, K. H., & Kim, D. J. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0057 · Cited by 20
Evidence-Based Cardiovascular Risk Management in Diabetes
Mooradian, A. D. (2019) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-019-00336-6 · Cited by 16
Cardiovascular Outcome Trials in Type 2 Diabetes: What Do They Mean for Clinical Practice?
Eckel, R. H., Farooki, A., Henry, R. R., Koch, G. G., & Leiter, L. A. (2019) · Clinical Diabetes · doi:10.2337/cd19-0001 · Cited by 17
Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date
Jia, X., Koh, S., Al Rifai, M., Blumenthal, R. S., & Virani, S. S. (2020) · Vascular Health and Risk Management · doi:10.2147/vhrm.s210149 · Cited by 14
Age related differences in acute coronary syndrome: An observation at a central hospital in Vietnam
Anh, D. T., Minh, H. V., Ho, A. B., Bao, T. Q., Hai, N. T. T., Nam, L. X., & Anh, T. D. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0012 · Cited by 16
Chen, V., Zurbau, A., Ahmed, A., Khan, T. A., Au‐Yeung, F., Chiavaroli, L., Mejía, S. B., Leiter, L. A., Jenkins, D. J. A., Kendall, C. W. C., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002784 · Cited by 23
Zhi, Y., Chen, R.-G., Zhao, J., Zhou, S.-X., & He, Z. (2024) · International Heart Journal · doi:10.1536/ihj.23-406 · Cited by 17
Treatment strategies for hypertension in patients with type 1 diabetes
Katsimardou, A., Imprialos, K. P., Stavropoulos, K., Sachinidis, A. G., Doumas, M. N., & Athyros, V. G. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1729124 · Cited by 17
Mogul, A., Leppien, E. E., Laughlin, E., & Spinler, S. A. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1817389 · Cited by 16
Diabetes mellitus and multiple myeloma; common features of two distinct entities
Tentolouris, A., Ntanasis‐Stathopoulos, I., Eleftheriadou, I., Malandrakis, P., Tzeravini, E., & Gavriatopoulou, M. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3535 · Cited by 16
Newman, J. D., Berger, J. S., & Ladapo, J. A. (2019) · Diabetes Care · doi:10.2337/dc18-1554 · Cited by 13
Raghavan, S., Ho, Y.-L. A., Kini, V., Rhee, M. K., Vassy, J. L., GAGNON, D. R., Cho, K., Wilson, P. W. F., & Phillips, L. S. (2019) · Diabetes Care · doi:10.2337/dc19-0686 · Cited by 15
Choi, A. D., Parwani, P. J., Michos, E. D., Lee, J., Singh, V., Fentanes, E., Lopez‐Mattei, J., Gulati, M., Nasir, K., Nieman, K., et al. (2019) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2019.12.003 · Cited by 13
Lee, D., Chun, E. J., Moon, J. H., Yun, H. M., & Lim, S. K. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14147 · Cited by 15
Diabetes and CVD Risk: Special Considerations in African Americans Related to Care
Wittwer, J. A., Golden, S. H., & Joseph, J. J. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-00648-2 · Cited by 14
Armario, P., Brotons, C., Elosúa, R., de Leciñana, M. A., Castro, A., Clarà, A. B. I., Cortés, O., Rodríguez, Á. D., Herranz, M., Justo, S., et al. (2020) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2020.07.004 · Cited by 15
Mineoka, Y., Ishii, M., Hashimoto, Y., Yuge, H., Toyoda, M., Nakamura, N., Katsumi, Y., & Fukui, M. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002070 · Cited by 13
El-Medany, A. H., Hammadi, S. H., Khalifa, H. M., Ghazala, R. A., & Mohammed, H. S. Z. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12765 · Cited by 13
Use of Troponin as a predictor for cardiovascular diseases in patients with type 2 Diabetes Mellitus
Bellia, C., Lombardo, M., & Della‐Morte, D. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.007 · Cited by 12
de Vries, S. T., Pena, M. J., Tye, S. C., Peters, S. A. E., van Raalte, D. H., Arnott, C. G., Voors, A. A., Mol, P. G. M., Denig, P., & Heerspink, H. J. L. (2024) · Diabetologia · doi:10.1007/s00125-024-06325-y · Cited by 13
Wang, B., Zhang, H., Sun, Y. B., Tan, X. W., Zhang, J., Wang, N., & Lu, Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3642 · Cited by 15
Zhang, W., Zhang, L., Xiao, C., Wu, X., Cui, H., Yang, C., Yan, P., Tang, M., Wang, Y., Chen, L., et al. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002894 · Cited by 14
Acampa, W., Assante, R., Zampella, E., Petretta, M., & Cuocolo, A. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01846-1 · Cited by 9
Weeda, E. R., Bishu, K. G., Ward, R. C., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01730-8 · Cited by 13
Pimenta, N. M., Félix, I. B., Monteiro, D., Marques, M. M., & Guerreiro, M. P. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.883354 · Cited by 13
Kristensen, A. M. D., Pareek, M., Kragholm, K. H., Torp-Pedersen, C. T., McEvoy, J. W., & Prescott, E. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad092 · Cited by 12
Milder, T. Y., STOCKER, S. L., Samocha‐Bonet, D., Day, R. O., & Greenfield, J. R. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02732-y · Cited by 15
Alfian, S. D., Abdulah, R., Denig, P., van Boven, J. F. M., & Hak, E. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034507 · Cited by 18
Galarza, E. J., Martínez‐Sánchez, F. D., Javier‐Montiel, C. I., Medina-Urrutia, A. X., Posadas‐Romero, C., González-Salazar, M. D. C., Osorio‐Alonso, H., Arellano-Buendía, A. S., & Juárez-Rojas, J. G. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.13942 · Cited by 12
Kim, Y. T., Chung, H. J., Park, B. R., Kim, Y. Y., Lee, J. H., Kang, D. R., Kim, J., Lee, M. Y., & Lee, J. Y. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15320 · Cited by 13
Höskuldsdóttir, G., Franzén, S., Eeg‐Olofsson, K., & Eliasson, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-16135-0 · Cited by 14
Bao, W., Zhang, M., Li, N., Yao, Z., & Sun, L. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03408-w · Cited by 13
Jung, M., & Lee, S. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00723-3 · Cited by 13
Ghosal, S., Sinha, B., Ved, J., & Biswas, M. (2020) · Indian Heart Journal · doi:10.1016/j.ihj.2020.03.010 · Cited by 11
Metadata
- Authors
- American Diabetes Association
- Corresponding author
- American Diabetes Association
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-12-07
- Volume
- 42
- Issue
- Supplement_1
- Pages
- S103-S123
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W4213222556
- Semantic Scholar
- b0a37d21ada65be89484f4b750bf45f281a7f7c5
- Cited by
- 471
- References
- 172
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 20 · 2023: 35 · 2022: 65 · 2021: 84 · 2020: 134 · 2019: 109
- FWCI
- 12.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- cardiovascular disease, cardiovascular risk management, diabetes mellitus, clinical guidelines, quality of care, treatment goals, level of evidence
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Humans, Risk Management, Societies, Medical, United States, Practice Guidelines as Topic, Diabetic Cardiomyopathies, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.